AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2025
Jul 31, 2025
33298_dirs_2025-07-31_914e049e-2ce9-40d7-adcb-f5279700bee1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2025-07-22
Reporting Person: Dray Shayna Webb (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 215000 | Direct |
Footnotes
F1: Includes 10,000 common stock shares granted on November 8, 2023 that vest on July 1, 2026 and 13,000 common stock shares granted on May 7, 2024 that vest on January 1, 2026. Includes 60,000 restricted stock units granted on April 1, 2025 with 20,000 units vesting on January 1, 2026 and 40,000 units vesting on January 1, 2027. Each restricted stock unit represents a contingent right to receive one share of common stock.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17